Macquarie Group LTD Eli Lilly & CO Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Macquarie Group LTD holds 342,421 shares of LLY stock, worth $258 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

342,421

Previous 362,920 5.65%

Holding current value

$258 Million

Previous $329 Million 7.67%

% of portfolio

0.34%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $15.8 Million - $19.7 Million	-20,499 Reduced 5.65%	342,421 $303 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $84.1 Million - $105 Million	-115,960 Reduced 24.21%	362,920 $329 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $63 Million - $84.4 Million	106,467 Added 28.59%	478,880 $373 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $6.37 Million - $7.51 Million	12,135 Added 3.37%	372,413 $217 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $133,018 - $183,385	306 Added 0.09%	360,278 $194 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $10.6 Million - $14.1 Million	-30,080 Reduced 7.71%	359,972 $169 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $44.5 Million - $52.3 Million	-143,293 Reduced 26.87%	390,052 $134 Million
Q4 2022 Feb 21, 2023	SELL	$321.55 - $374.67 $80.1 Million - $93.3 Million	-249,136 Reduced 31.84%	533,345 $195 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $128 Million - $146 Million	-431,015 Reduced 35.52%	782,481 $253 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $119 Million - $139 Million	-425,773 Reduced 25.97%	1,213,496 $393 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $833,384 - $1.04 Million	3,551 Added 0.22%	1,639,269 $469 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $86.7 Million - $108 Million	385,618 Added 30.85%	1,635,718 $452 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $2.75 Million - $3.38 Million	12,402 Added 1.0%	1,250,100 $289 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $147 Million - $190 Million	811,525 Added 190.42%	1,237,698 $284 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $6.51 Million - $8.43 Million	39,629 Added 10.25%	426,173 $79.6 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $836,118 - $1.11 Million	-6,409 Reduced 1.63%	386,544 $65.3 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $2.42 Million - $2.8 Million	-16,546 Reduced 4.04%	392,953 $58.2 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $3.34 Million - $4.02 Million	-24,499 Reduced 5.64%	409,499 $67.2 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $2.71 Million - $3.35 Million	-22,766 Reduced 4.98%	433,998 $60.2 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $18.3 Million - $22.7 Million	171,558 Added 60.15%	456,764 $60 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.66 Million - $1.8 Million	-15,508 Reduced 5.16%	285,206 $31.9 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $145,245 - $169,538	-1,311 Reduced 0.43%	300,714 $33.3 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $7.52 Million - $8.85 Million	-67,576 Reduced 18.28%	302,025 $39.2 Million
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $5.07 Million - $5.68 Million	47,837 Added 14.87%	369,601 $42.8 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $203,230 - $254,002	2,367 Added 0.74%	321,764 $34.5 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $2.7 Million - $3.1 Million	35,653 Added 12.57%	319,397 $27.3 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $890 - $1,051	-12 Reduced -0.0%	283,744 $22 Million
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $4.15 Million - $4.45 Million	-50,589 Reduced 15.13%	283,756 $24.1 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $25.8 Million - $28.6 Million	334,345	334,345 $28.6 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Eli Lilly & CO Transaction History